Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
Clinical trial NCT03555877 · COMPLETED
Trial details
- NCT number
- NCT03555877
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2022-07-21
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.